What Is SS-31? Exploring Mitochondrial Peptide Research

Mitochondria are highly specialized cellular structures involved in energy metabolism, signaling, redox biology, and other fundamental processes. Because of these roles, mitochondrial structure and function are studied across numerous areas of basic and translational science.

One compound that has received considerable attention in this field is SS-31, a synthetic tetrapeptide also widely known in the scientific literature as elamipretide.

SS-31 is particularly interesting to researchers because of its interactions with the inner mitochondrial membrane and a specialized phospholipid called cardiolipin. Research into these interactions has contributed to a broader scientific discussion about mitochondrial membrane organization, bioenergetics, oxidative processes, and cellular stress.

This article examines what SS-31 is, why mitochondria are important to its study, and what researchers have investigated about its molecular interactions.

What Is SS-31?

SS-31 belongs to a group of compounds commonly referred to as Szeto-Schiller peptides, or SS peptides.

It is a small synthetic peptide composed of four amino-acid residues and is therefore classified as a tetrapeptide. Its sequence is commonly represented in scientific literature as:

D-Arg-Dmt-Lys-Phe-NH₂

Here, Dmt refers to 2′,6′-dimethyltyrosine.

SS-31 has appeared under several names in scientific and regulatory literature, including:

• SS-31
• elamipretide
• MTP-131
• Bendavia

The FDA’s substance database identifies SS-31 and MTP-131 among the names associated with elamipretide.

The compound became a subject of mitochondrial research because studies found that SS peptides could interact with mitochondrial membranes, particularly the inner mitochondrial membrane. Published research and reviews available through PubMed provide additional background on the structure and mitochondrial research surrounding elamipretide.

Understanding why that matters requires some background on mitochondrial structure.

Why Are Mitochondria Important?

Mitochondria are often introduced simply as the structures responsible for producing cellular energy. While energy metabolism is one of their major functions, their biology is considerably more complex.

Mitochondria participate in processes involving:

• oxidative phosphorylation
• cellular metabolism
• redox signaling
• calcium regulation
• programmed cell death
• cellular stress responses

A mitochondrion contains both an outer mitochondrial membrane and an inner mitochondrial membrane.

The inner membrane is especially important because it contains components of the electron transport chain and ATP synthase. These molecular systems participate in oxidative phosphorylation, the process through which cells generate much of their ATP under aerobic conditions.

The inner membrane is also extensively folded into structures called cristae.

These folds are not merely structural features. Their organization helps establish the membrane environment in which many components of mitochondrial bioenergetics operate.

This makes the composition and organization of the inner mitochondrial membrane an important subject of laboratory investigation.

SS-31 and the Inner Mitochondrial Membrane

One of the defining areas of SS-31 research involves its association with the inner mitochondrial membrane.

Early research into Szeto-Schiller peptides focused partly on their unusual ability to localize to mitochondria. Subsequent work increasingly examined interactions between SS-31 and cardiolipin, a phospholipid strongly associated with the inner mitochondrial membrane.

This shifted the scientific discussion surrounding SS-31.

Rather than viewing the compound simply through the lens of direct reactive oxygen species scavenging, researchers began examining how interactions with mitochondrial membrane lipids might influence broader aspects of mitochondrial organization and bioenergetics.

A 2025 review indexed by PubMed discusses the evolving understanding of elamipretide’s mitochondrial mechanisms, including research surrounding cardiolipin interactions.

What Is Cardiolipin?

Cardiolipin is an unusual phospholipid that is highly enriched in the inner mitochondrial membrane.

It contributes to the structural and functional environment surrounding multiple proteins involved in mitochondrial activity.

Among other areas, cardiolipin has been studied in relation to:

• mitochondrial membrane organization
• cristae architecture
• electron transport chain complexes
• oxidative phosphorylation
• interactions with cytochrome c
• mitochondrial protein organization

Because cardiolipin is closely connected with mitochondrial membrane architecture, compounds that interact with it provide researchers with a way to investigate relationships between membrane chemistry and mitochondrial function.

SS-31 is one such compound.

Experimental studies indicate that SS-31 can associate with cardiolipin through electrostatic and hydrophobic interactions. Researchers have consequently investigated how this association relates to the physical and biochemical environment of the inner mitochondrial membrane.

For additional scientific context, an earlier peer-reviewed review available through PubMed Central discusses SS-31 in relation to cardiolipin, cytochrome c, and mitochondrial bioenergetics.

SS-31 and Cytochrome c

Another important part of SS-31 research concerns cytochrome c.

Cytochrome c is a small protein associated with the inner mitochondrial membrane. One of its fundamental roles is transferring electrons between components of the mitochondrial electron transport chain.

Its interactions with cardiolipin are complex and have been studied extensively.

Research has indicated that the association of SS-31 with cardiolipin can modify aspects of the cardiolipin-cytochrome c interaction. This has led investigators to examine SS-31 as a molecular tool for understanding how membrane lipids influence electron transfer, oxidative chemistry, and mitochondrial membrane organization.

These findings should be interpreted as mechanistic research observations rather than evidence that every downstream biological effect attributed to SS-31 has been completely established.

Mitochondrial systems contain interconnected proteins, lipids, metabolites, and signaling pathways. Researchers are continuing to investigate how these systems interact.

Mitochondrial Cristae and Membrane Architecture

Cristae are folds of the inner mitochondrial membrane.

Their shape and organization help create the structural environment needed for mitochondrial respiratory machinery. Cardiolipin contributes to this membrane architecture and interacts with several proteins involved in mitochondrial bioenergetics.

Because SS-31 associates with cardiolipin, researchers have investigated whether the peptide can influence cardiolipin-dependent membrane organization and protein interactions.

This area has expanded beyond simplified descriptions of SS-31 as an “antioxidant peptide.”

For example, research indexed in PubMed examining the mitochondrial protein interaction landscape of SS-31 used chemical cross-linking and mass spectrometry to investigate mitochondrial proteins associated with the peptide. The study identified interactions involving proteins associated with cardiolipin and mitochondrial bioenergetic processes.

Such findings have encouraged researchers to examine SS-31 within a broader framework involving mitochondrial membrane organization, lipid-protein interactions, and bioenergetic machinery.

SS-31 and Mitochondrial Bioenergetics

Bioenergetics is the study of how biological systems transform and use energy.

Within mitochondria, much of this research centers on the electron transport chain and oxidative phosphorylation.

Electrons move through respiratory complexes located within the inner mitochondrial membrane. This process contributes to the proton gradient that ultimately supports ATP synthesis.

Because SS-31 interacts with a lipid closely associated with these membrane systems, researchers have investigated experimental measurements including:

• mitochondrial respiration
• electron transport
• membrane organization
• ATP-related bioenergetic measurements
• mitochondrial protein interactions
• reactive oxygen species
• cardiolipin-dependent processes

Research into these mechanisms is discussed in greater detail in the peer-reviewed literature, including this review of elamipretide’s structure and mitochondrial mechanisms.

Importantly, these are research endpoints. Changes observed in isolated mitochondria, cultured cells, tissues, or animal models cannot automatically be interpreted as outcomes in humans.

Experimental model, concentration, assay design, tissue type, exposure conditions, and numerous other variables can affect research findings.

What About Oxidative Stress?

Oxidative stress frequently appears in discussions of mitochondrial research.

During normal mitochondrial metabolism, reactive oxygen species, commonly abbreviated ROS, can be generated. ROS are not inherently abnormal. At controlled levels, they participate in cellular signaling and other biological processes.

Problems can arise experimentally when the balance between reactive species production and cellular regulatory systems changes substantially.

Early research into SS peptides emphasized their potential radical-scavenging properties. SS-31 contains dimethyltyrosine, which contributed to this area of investigation.

However, the scientific understanding of SS-31 has become more nuanced.

Current research does not describe its mitochondrial activity solely in terms of directly scavenging reactive species. Investigators have increasingly studied how its interaction with cardiolipin and the inner mitochondrial membrane may affect mitochondrial organization and the conditions under which reactive species are generated.

This distinction is important because mitochondrial redox biology involves considerably more than labeling a compound an “antioxidant.”

SS-31 as a Research Tool

From a laboratory perspective, SS-31 is interesting because it allows researchers to investigate several interconnected questions.

For example, experimental work can explore how mitochondrial membrane lipids interact with proteins, how cardiolipin contributes to cristae architecture, how mitochondrial respiratory machinery is organized, and how changes in membrane organization correspond with measurable bioenergetic parameters.

Depending on the model and research question, investigators may examine endpoints involving mitochondrial respiration, membrane properties, oxidative processes, protein interactions, or cellular metabolism.

As with any experimental compound, conclusions must remain specific to the model and methods used.

An observation in isolated mitochondria does not necessarily predict an observation in cultured cells. A cellular finding does not necessarily predict an animal result. Likewise, preclinical findings cannot by themselves establish clinical effects.

Maintaining those distinctions is fundamental to responsible interpretation of peptide research.

Is SS-31 the Same as Elamipretide?

The terms are closely related, but context matters.

SS-31 is the research designation historically used for the peptide that became known as elamipretide. The FDA’s substance database lists SS-31 among the names associated with elamipretide.

There is also an important regulatory distinction.

In September 2025, the U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) for a specific indication involving adult and pediatric patients with Barth syndrome weighing at least 30 kg. The official FDA-approved Forzinity prescribing information provides the applicable indication and regulatory information.

That regulatory approval applies to the FDA-approved pharmaceutical product and its specific labeled indication. It should not be interpreted as approval of research-grade SS-31 materials, nor does it establish other SS-31 products as equivalent to the approved drug.

Prism Peptides does not provide medical advice, treatment protocols, dosing recommendations, or administration guidance. Research products offered by Prism Peptides are intended strictly for laboratory research and are not intended for human, veterinary, or diagnostic use.

Why SS-31 Remains Scientifically Interesting

SS-31 occupies an interesting place in peptide science because its research connects peptide chemistry with mitochondrial membrane biology.

Rather than interacting only with a conventional protein receptor, much of the mechanistic research surrounding SS-31 centers on its relationship with a specialized mitochondrial phospholipid.

That has made the compound relevant to broader scientific questions involving:

• cardiolipin biology
• mitochondrial membrane architecture
• cristae organization
• lipid-protein interactions
• oxidative phosphorylation
• mitochondrial bioenergetics
• redox biology

The field has also changed over time.

Earlier descriptions often focused heavily on antioxidant activity. More recent research has expanded the proposed mechanistic picture to include cardiolipin interactions, mitochondrial membrane electrostatics, protein organization, and other aspects of mitochondrial physiology.

This evolution is a useful reminder that mechanistic models in peptide research are rarely static. They change as new experimental methods and evidence become available.

The Importance of Careful Interpretation

Mitochondrial peptide research can easily be oversimplified.

A study reporting a change in mitochondrial respiration, ROS production, membrane structure, or ATP-related measurements does not establish a general health outcome. It establishes an observation under a particular experimental set of conditions.

Responsible interpretation therefore requires researchers to consider factors such as:

• the experimental model
• study design
• controls
• assay methodology
• sample size
• exposure conditions
• reproducibility
• statistical analysis
• whether findings have been independently replicated

This distinction is especially important when research compounds are discussed outside laboratory settings.

Mechanistic evidence, preclinical evidence, clinical investigation, and regulatory approval represent different categories of evidence and should not be treated as interchangeable.

Final Perspective

SS-31 provides researchers with an interesting molecular system for studying mitochondrial biology.

As a small synthetic tetrapeptide with an affinity for the inner mitochondrial membrane and cardiolipin, it has contributed to investigations of mitochondrial membrane architecture, cytochrome c interactions, oxidative processes, respiratory machinery, and cellular bioenergetics.

Research into SS-31 also demonstrates how scientific understanding can evolve. Initial hypotheses emphasizing direct antioxidant activity have expanded into a more complex model involving mitochondrial lipids, membrane structure, protein interactions, and bioenergetic organization.

There are still questions to investigate, and findings must be interpreted according to the experimental context in which they were produced.

For researchers and readers interested in mitochondrial peptide science, SS-31 therefore offers a useful example of how peptide chemistry can be used to investigate the molecular organization of one of the cell’s most complex organelles.